Annual Drug Patent Expirations for TIBSOVO
Tibsovo is a drug marketed by Servier and is included in one NDA. It is available from two suppliers. There are nine patents protecting this drug.
Drug patent litigation for TIBSOVO.
This drug has one hundred and thirty-eight patent family members in forty-two countries.
The generic ingredient in TIBSOVO is ivosidenib. Two suppliers are listed for this compound. Additional details are available on the ivosidenib profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com